Menopur 600IU MV
| Other Names: | Repronex |
| Active Ingredient: | Menotropins |
| Dosage: | Menopur 600IU Vial |
| Maker: | Ferring (Menopur) |
$590.00
Menotropin is a medicine that contains follicle stimulating hormone (FSH) and luteinizing hormone (LH). These hormones stimulate healthy ovaries to make eggs. This medicine is given by injection. Only use it as instructed by your physician.
Description
MENOPUR 600IU MV
Menopur 600IU MV is also a medication used in fertility treatment. It is a mixture of two hormones, follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which are naturally produced in the body and play a key role in the development and maturation of follicles in the ovaries. Like Menopur 1,200IU MV
Menopur 600IU MV is typically used in women who are undergoing assisted reproductive technologies, such as in vitro fertilization (IVF), to help stimulate the growth and maturation of multiple follicles in the ovaries. It is also administered via subcutaneous injection.
The dosage and duration of treatment with Menopur 600IU MV may vary depending on the individual’s age, weight, and medical history, as well as the specific fertility treatment plan being followed. It is important to follow your healthcare provider’s instructions closely and to undergo regular monitoring to ensure the medication is working as intended.
As with all medications, Menopur 600IU MV may cause side effects in some people. Common side effects may include injection site reactions, abdominal pain, bloating, and headaches. In rare cases, it may also cause more serious side effects, such as ovarian hyperstimulation syndrome (OHSS) or blood clots. It is important to discuss any concerns or questions with your healthcare provider before starting treatment.
As with all medications, Menopur 600IU MV may cause side effects in some people. Common side effects may include injection site reactions, abdominal pain, bloating, and headaches. In rare cases, it may also cause more serious side effects, such as ovarian hyperstimulation syndrome (OHSS) or blood clots. It is important to discuss any concerns or questions with your healthcare provider before starting treatment.
